| |
 |
|
Class Information
Number: 977/917
Name: Nanotechnology > Specified use of nanostructure > For medical, immunological, body treatment, or diagnosis > Therapeutic or pharmaceutical composition > Vaccine
Description: Subject matter wherein the nanostructure is part of an adjuvant adapted for producing an immunological response and vaccination against a disease or infection.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6660500 |
Production of peptides in plants as viral coat protein fusions |
Dec. 9, 2003 |
| 6638513 |
Neisseria meningitidis serogroup B Glycoconjugates |
Oct. 28, 2003 |
| 6585973 |
Method for preparing solid phase conjugated vaccine |
Jul. 1, 2003 |
| 6491921 |
Avian polyomavirus vaccines in psittacine birds |
Dec. 10, 2002 |
| 6251406 |
Attenuated microorganism strains and their uses |
Jun. 26, 2001 |
| 6248582 |
Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV |
Jun. 19, 2001 |
| 6245532 |
Method for producing influenza hemagglutinin multivalent vaccines |
Jun. 12, 2001 |
| 6231864 |
Strategically modified hepatitis B core proteins and their derivatives |
May. 15, 2001 |
| 6228368 |
Papilloma virus capsomere formulations and method of use |
May. 8, 2001 |
| 6210961 |
Recombinant infectious bovine rhinotracheitis virus comprising foreign DNA inserted into a non-essential region of a infectious bovine rhinotracheitis virus genome |
Apr. 3, 2001 |
| 6165471 |
Homogeneous human papillomavirus capsomere containing compositions, methods for manufacture, and use thereof as diagnostic, prophylactic or therapeutic agents |
Dec. 26, 2000 |
| 6132732 |
Parvovirus capsids |
Oct. 17, 2000 |
| 6096291 |
Mucosal administration of substances to mammals |
Aug. 1, 2000 |
| 6017537 |
Formyl methionyl peptide vaccine adjuvant |
Jan. 25, 2000 |
| 6013262 |
Recombinant papilloma virus L1 |
Jan. 11, 2000 |
| 6001371 |
Parvovirus capsids |
Dec. 14, 1999 |
| 6001395 |
Polymeric lamellar substrate particles for drug delivery |
Dec. 14, 1999 |
| 5985641 |
Non-infectious, replication-impaired, immunogenic human immunodeficiency virus type 1 retrovirus-like particles with multiple genetic deficiencies |
Nov. 16, 1999 |
| 5985284 |
Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides |
Nov. 16, 1999 |
| 5977438 |
Production of peptides in plants as viral coat protein fusions |
Nov. 2, 1999 |
| 5961970 |
Submicron emulsions as vaccine adjuvants |
Oct. 5, 1999 |
| 5928647 |
Inducing cytotoxic T lymphocyte responses |
Jul. 27, 1999 |
| 5919466 |
Method for improving the yield of immunoantibodies in the vaccination of animals and humans |
Jul. 6, 1999 |
| 5902565 |
Spray dried vaccine preparation comprising aluminium adsorbed immunogens |
May. 11, 1999 |
| 5888516 |
Recombinant papillomavirus vaccines |
Mar. 30, 1999 |
| 5876731 |
Tandem synthetic HIV-1 Peptides |
Mar. 2, 1999 |
| 5866137 |
Self-assembled, non-infectious, non-replicating; immunogenic retrovirus-like particles comprising modified HIV genomes devoid of long terminal repeats and chimeric envelope glycoproteins |
Feb. 2, 1999 |
| 5849475 |
Immunoassay diagnostic kit containing antigens derived from self-assembled, non-infectious, non-replicating, immunogenic retrovirus-like particles comprising modified HIV genomes and chimeric |
Dec. 15, 1998 |
| 5846951 |
Pharmaceutical compositions |
Dec. 8, 1998 |
| 5833995 |
Use of bluetongue virus proteins as vaccine components |
Nov. 10, 1998 |
| 5827647 |
Parvovirus capsids |
Oct. 27, 1998 |
| 5820870 |
Recombinant human papillomavirus type 18 vaccine |
Oct. 13, 1998 |
| 5716637 |
Solid fat nanoemulsions as vaccine delivery vehicles |
Feb. 10, 1998 |
| 4269821 |
Biological materials |
May. 26, 1981 |
|
|
|
